Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Influenza

Free Subscription 29.04.2024 3 Arch Virol 1 Biochem Soc Trans 4 BMJ 1 J Exp Med 3 JAMA 1 Lancet 4 Minerva Pediatr (Torino) 4 MMWR Morb Mortal Wkly Rep 3 N Engl J Med 2 PLoS Comput Biol 32 PLoS One 8 Vaccine 6 Virus Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Arch Virol

1. TARE DS, Keng SS, Walimbe AM, Pawar SD, et al
   Phylogeography and gene pool analysis of highly pathogenic avian influenza H5N1 viruses reported in India from 2006 to 2021.
   Arch Virol. 2024;169:111.
   PubMed         Abstract available
   
   
2. YOUSFI FZE, Haroun AE, Nebhani C, Belayachi J, et al
   Prevalence of the protective OAS1 rs10774671-G allele against severe COVID-19 in Moroccans: implications for a North African Neanderthal connection.
   Arch Virol. 2024;169:109.
   PubMed         Abstract available
   
   
3. HAIDER SA, Jamal Z, Tahir F, Salman M, et al
   Genomic characterization of human respiratory syncytial virus circulating in Islamabad, Pakistan, during an outbreak in 2022-2023.
   Arch Virol. 2024;169:106.
   PubMed         Abstract available
   
   

   
   Biochem Soc Trans

4. MARINUS T, Foster TL, Tych KM
   The application of single-molecule optical tweezers to study disease-related structural dynamics in RNA.
   Biochem Soc Trans. 2024;52:899-909.
   PubMed         Abstract available
   
   

   
   BMJ

5. 
   Seven days in medicine: 17-23 April 2024.
   BMJ. 2024;385:q924.
   PubMed        
   
   
6. LOOI MK
   Sixty seconds on . . . bird flu.
   BMJ. 2024;385:q951.
   PubMed        
   
   
7. KANG D
   The ever looming shadow of caregiving.
   BMJ. 2024;385:q726.
   PubMed        
   
   
8. LAUNER J
   John Launer: Doctors as activists.
   BMJ. 2024;385:q939.
   PubMed        
   
   

   
   J Exp Med

9. MACLEAN AJ, Bonifacio JPPL, Oram SL, Mohsen MO, et al
   Regulation of pulmonary plasma cell responses during secondary infection with influenza virus.
   J Exp Med. 2024;221:e20232014.
   PubMed         Abstract available
   
   

   
   JAMA

10. HARRIS E
    Antidepressant Prescriptions for Female Teens Surged After Pandemic.
    JAMA. 2024;331:1266.
    PubMed        
    
    
11. HARRIS E
    Deaths From Excessive Drinking Rose in the US During Pandemic.
    JAMA. 2024;331:1355.
    PubMed        
    
    
12. HARRIS E
    Meta-Analysis: "Limited" Benefits to Rapid Viral Tests in EDs.
    JAMA. 2024;331:1355.
    PubMed        
    
    

    
    Lancet

13. DEVI S
    Swedish NGOs are reeling after government cuts.
    Lancet. 2024;403:1527.
    PubMed        
    
    

    
    Minerva Pediatr (Torino)

14. MEMEO A, Priano D, Caldarini C, Trezza P, et al
    How the pandemic spread of COVID-19 affected children's traumatology in Italy: changes of numbers, anatomical locations, and severity.
    Minerva Pediatr (Torino). 2024;76:167-172.
    PubMed         Abstract available
    
    
15. GARG D, Bhalla K, Nanda S, Gupta A, et al
    Vitamin D status in children with community acquired pneumonia and its association with severity: a hospital-based study.
    Minerva Pediatr (Torino). 2024;76:227-235.
    PubMed         Abstract available
    
    
16. LEE S, Erdem G, Yasuhara J
    Multisystem inflammatory syndrome in children associated with COVID-19: from pathophysiology to clinical management and outcomes.
    Minerva Pediatr (Torino). 2024;76:268-280.
    PubMed         Abstract available
    
    
17. PEROS TE, Besseling MR, VAN Zanten E, VAN Heerde M, et al
    Increase in pediatric intensive care mortality after the Coronavirus pandemic.
    Minerva Pediatr (Torino). 2023 Sep 21. doi: 10.23736/S2724-5276.23.07288.
    PubMed        
    
    

    
    MMWR Morb Mortal Wkly Rep

18. FRANKLIN D, Barbre K, Rowe TA, Reses HE, et al
    COVID-19 Vaccination Coverage, and Rates of SARS-CoV-2 Infection and COVID-19-Associated Hospitalization Among Residents in Nursing Homes - National Healthcare Safety Network, United States, October 2023-February 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:339-344.
    PubMed         Abstract available
    
    
19. ZAMBRANO LD, Newhams MM, Simeone RM, Payne AB, et al
    Durability of Original Monovalent mRNA Vaccine Effectiveness Against COVID-19 Omicron-Associated Hospitalization in Children and Adolescents - United States, 2021-2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:330-338.
    PubMed         Abstract available
    
    
20. PANAGIOTAKOPOULOS L, Godfrey M, Moulia DL, Link-Gelles R, et al
    Use of an Additional Updated 2023-2024 COVID-19 Vaccine Dose for Adults Aged >/=65 Years: Recommendations of the Advisory Committee on Immunization Practices - United States, 2024.
    MMWR Morb Mortal Wkly Rep. 2024;73:377-381.
    PubMed         Abstract available
    
    
21. SMITH-JEFFCOAT SE, Mellis AM, Grijalva CG, Talbot HK, et al
    SARS-CoV-2 Viral Shedding and Rapid Antigen Test Performance - Respiratory Virus Transmission Network, November 2022-May 2023.
    MMWR Morb Mortal Wkly Rep. 2024;73:365-371.
    PubMed         Abstract available
    
    

    
    N Engl J Med

22. WANG Y, Hu H, Cao B
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19. Reply.
    N Engl J Med. 2024;390:1534-1535.
    PubMed        
    
    
23. SELVI-SABATER P, de la Rubia Orti JE, Urbieta-Sanz E
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1534.
    PubMed        
    
    
24. MOSER CB, Li JZ, Hughes MD
    Oral Simnotrelvir for Adult Patients with Mild-to-Moderate Covid-19.
    N Engl J Med. 2024;390:1533-1534.
    PubMed        
    
    

    
    PLoS Comput Biol

25. BENISTON E, Skittrall JP
    Locations and structures of influenza A virus packaging-associated signals and other functional elements via an in silico pipeline for predicting constrained features in RNA viruses.
    PLoS Comput Biol. 2024;20:e1012009.
    PubMed         Abstract available
    
    
26. LISON A, Abbott S, Huisman J, Stadler T, et al
    Generative Bayesian modeling to nowcast the effective reproduction number from line list data with missing symptom onset dates.
    PLoS Comput Biol. 2024;20:e1012021.
    PubMed         Abstract available
    
    

    
    PLoS One

27. YAZDANI A, Mozaffarpur SA, Ebrahimi P, Shirafkan H, et al
    Comorbidities affecting re-admission and survival in COVID-19: Application of joint frailty model.
    PLoS One. 2024;19:e0301209.
    PubMed         Abstract available
    
    
28. TIAN J
    Rural household vulnerability and COVID-19: Evidence from India.
    PLoS One. 2024;19:e0301662.
    PubMed         Abstract available
    
    
29. CHAZE M, Meriade L, Rochette C, Bailly M, et al
    Relying on the French territorial offer of thermal spa therapies to build a care pathway for long COVID-19 patients.
    PLoS One. 2024;19:e0302392.
    PubMed         Abstract available
    
    
30. MESESAN-SCHMITZ L, Coman C, Stanciu C, Bucur V, et al
    Changes in parenting behavior in the time of COVID-19: A mixed method approach.
    PLoS One. 2024;19:e0302125.
    PubMed         Abstract available
    
    
31. HAMASHA MM, Alomari AJ, Bani-Irshid AH
    The effect of the COVID-19 pandemic crisis on the Jordanian higher education system.
    PLoS One. 2024;19:e0299531.
    PubMed         Abstract available
    
    
32. RAZAI MS, Mansour R, Ravindran P, Freeman S, et al
    Facilitators and barriers to vaccination uptake in pregnancy: A qualitative systematic review.
    PLoS One. 2024;19:e0298407.
    PubMed         Abstract available
    
    
33. FANG F, Clemens JD, Zhang ZF, Brewer TF, et al
    Impact of SARS-CoV-2 vaccines on Covid-19 incidence and mortality in the United States.
    PLoS One. 2024;19:e0301830.
    PubMed         Abstract available
    
    
34. CHOUAIRI F, Jaffe E, Minhas AMK, Fudim M, et al
    Brief report: Effect of cardiac multi-morbidity on COVID hospitalization outcomes.
    PLoS One. 2024;19:e0301898.
    PubMed         Abstract available
    
    
35. SHAFIABADY N, Hadjinicolaou N, Hettikankanamage N, MohammadiSavadkoohi E, et al
    eXplainable Artificial Intelligence (XAI) for improving organisational regility.
    PLoS One. 2024;19:e0301429.
    PubMed         Abstract available
    
    
36. BEST LG, Erdei E, Haack K, Kent JW Jr, et al
    Genetic variant rs1205 is associated with COVID-19 outcomes: The Strong Heart Study and Strong Heart Family Study.
    PLoS One. 2024;19:e0302464.
    PubMed         Abstract available
    
    
37. WHITE A, Iverson G, Wright L, Fallon JT 3rd, et al
    Wastewater based epidemiology as a surveillance tool during the current COVID-19 pandemic on a college campus (East Carolina University) and its accuracy in predicting SARS-CoV-2 outbreaks in dormitories.
    PLoS One. 2024;19:e0289906.
    PubMed         Abstract available
    
    
38. ZHANG Q, Tiwari S, Wen J, Wang S, et al
    Induction of neutralizing antibodies against SARS-CoV-2 variants by a multivalent mRNA-lipid nanoparticle vaccine encoding SARS-CoV-2/SARS-CoV Spike protein receptor-binding domains in mice.
    PLoS One. 2024;19:e0300524.
    PubMed         Abstract available
    
    
39. MILANTI A, Chan DNS, Choi KC, So WKW, et al
    eHealth literacy of migrant domestic workers in Hong Kong in the COVID-19 pandemic: A mixed methods study.
    PLoS One. 2024;19:e0296893.
    PubMed         Abstract available
    
    
40. SILVA JUNIOR DDN, de Sousa Mata AN, Silva de Medeiros GCB, Marques MV, et al
    Factors associated with mortality of elderly people due to COVID-19: Protocol for systematic review and meta-analysis.
    PLoS One. 2024;19:e0289576.
    PubMed         Abstract available
    
    
41. KHAMI MR, Karimi M, Folayan MO, Shamshiri AR, et al
    Patients' knowledge about dental emergencies, COVID-19 transmission, and required preparations in dental settings.
    PLoS One. 2024;19:e0301460.
    PubMed         Abstract available
    
    
42. VIANNA LS, Goncalves AL, Souza JA
    Analysis of learning curves in predictive modeling using exponential curve fitting with an asymptotic approach.
    PLoS One. 2024;19:e0299811.
    PubMed         Abstract available
    
    
43. ZHU Y, Kiran S, Salman M, Sherwani S, et al
    From crisis to responsibility: The role of industry type, leadership style, and regulatory environment in shaping post-COVID-19 CSR initiative.
    PLoS One. 2024;19:e0292732.
    PubMed         Abstract available
    
    
44. ERVIN J, Fleitas Alfonzo L, Taouk Y, Maheen H, et al
    Unpaid caregiving and mental health during the COVID-19 pandemic-A systematic review of the quantitative literature.
    PLoS One. 2024;19:e0297097.
    PubMed         Abstract available
    
    
45. PARK SY, Lee R, Newton C, Han G, et al
    How are people coping with working from home during the COVID-19 pandemic?: Experiences from the Netherlands and South Korea.
    PLoS One. 2024;19:e0301351.
    PubMed         Abstract available
    
    
46. KASSA ZY, Scarf V, Turkmani S, Fox D, et al
    Impact of COVID-19 on antenatal care provision at public hospitals in the Sidama region, Ethiopia: A mixed methods study.
    PLoS One. 2024;19:e0301994.
    PubMed         Abstract available
    
    
47. RAZAFINDRAKOTO M, Roubaud F, Castilho MR, Pero V, et al
    Investigating the 'Bolsonaro effect' on the spread of the Covid-19 pandemic: An empirical analysis of observational data in Brazil.
    PLoS One. 2024;19:e0288894.
    PubMed         Abstract available
    
    
48. MARTINEZ-RAMOS MM, Vyas M, Majari P, Seligman TH, et al
    COVID anomaly in the correlation analysis of S&P 500 market states.
    PLoS One. 2024;19:e0301238.
    PubMed         Abstract available
    
    
49. BADE V, Schmitz H, Tawiah BB
    Regional variations in vaccination against COVID-19 in Germany.
    PLoS One. 2024;19:e0296976.
    PubMed         Abstract available
    
    
50. HONG SH, Jiang X, Kwon H
    Use of bio-information and communication technology shortens time to peak at a lower height of the epidemic curve: An alternative to flattening for countries with early COVID-19 outbreaks.
    PLoS One. 2024;19:e0301669.
    PubMed         Abstract available
    
    
51. HUSSAIN A, Hussain Z, Gogate M, Dashtipour K, et al
    Impact of the Covid-19 pandemic on audiology service delivery: Observational study of the role of social media in patient communication.
    PLoS One. 2024;19:e0288223.
    PubMed         Abstract available
    
    
52. MAJRASHI TA, El Hassab MA, Mahmoud SH, Mostafa A, et al
    In vitro biological evaluation and in silico insights into the antiviral activity of standardized olive leaves extract against SARS-CoV-2.
    PLoS One. 2024;19:e0301086.
    PubMed         Abstract available
    
    
53. COGILL S, Nallamshetty S, Fullenkamp N, Heberer K, et al
    Predicting clinical outcomes of SARS-CoV-2 infection during the Omicron wave using machine learning.
    PLoS One. 2024;19:e0290221.
    PubMed         Abstract available
    
    
54. WANG J, Hu L, Zhang T, Liu J, et al
    Prevalence and predictors of prenatal depression during the COVID-19 pandemic: A multistage observational study in Beijing, China.
    PLoS One. 2024;19:e0298314.
    PubMed         Abstract available
    
    
55. DLAMINI M, Msolo L, Ehi Ebomah K, Nontongana N, et al
    A systematic review on the incidence of influenza viruses in wastewater matrices: Implications for public health.
    PLoS One. 2024;19:e0291900.
    PubMed         Abstract available
    
    
56. MAGANA-AVILA GR, Moreno E, Plata C, Carbajal-Contreras H, et al
    Effect of SARS-CoV-2 S protein on the proteolytic cleavage of the epithelial Na+ channel ENaC.
    PLoS One. 2024;19:e0302436.
    PubMed         Abstract available
    
    
57. LEDON-LLANES L, Contreras-Yanez I, Guaracha-Basanez GA, Valverde-Hernandez SS, et al
    Sexual and reproductive health while living with rheumatoid arthritis: The impact of the disease stage on patient perspectives.
    PLoS One. 2024;19:e0302284.
    PubMed         Abstract available
    
    
58. SARVANDIAN S, Hosseinpour S, Hoseinynejad K, Davasaz Irani R, et al
    Mental health status in healthcare workers during COVID-19 pandemic: An online questionnaire study in the southwest Iran.
    PLoS One. 2024;19:e0298058.
    PubMed         Abstract available
    
    

    
    Vaccine

59. SELLIES AJ, Knol MJ, de Melker HE, Bruijning-Verhagen PCJL, et al
    Non-specific effects of the inactivated influenza vaccine. A test-negative study: The inactivated influenza vaccine and SARS-CoV-2 infections.
    Vaccine. 2024 Apr 23:S0264-410X(24)00468-7. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
60. NOLAN MB, Chrenka E, Walker P, Steiner A, et al
    COVID-19 vaccine uptake among non-US-born populations in the United States, 2020-2022.
    Vaccine. 2024 Apr 11:S0264-410X(24)00443-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
61. KAINTH MK, Sembajwe GN, Ahn H, Qian M, et al
    Despite mandated primary series, health care personnel still hesitant about COVID-19 vaccine and immunizing children.
    Vaccine. 2024 Apr 11:S0264-410X(24)00442-0. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
62. ARCHER H, McCoy SI, Sears D, Kwan A, et al
    Indirect vaccine effectiveness in an outbreak of Alpha B.1.1.7 variant in a California state Prison, May 2021.
    Vaccine. 2024 Apr 6:S0264-410X(24)00368-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
63. SCHULTZE A, Martin I, Messina D, Bots S, et al
    A comparison of four self-controlled study designs in an analysis of COVID-19 vaccines and myocarditis using five European databases.
    Vaccine. 2024 Apr 5:S0264-410X(24)00330-X. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
64. NURDIN A, Movieta Nency Y, Maddeppungeng M, Sekartini R, et al
    Immunogenicity and safety of SARS-CoV-2 recombinant protein subunit vaccine (IndoVac) adjuvanted with alum and CpG 1018 in Indonesian adults: A phase 3, randomized, active-controlled, multicenter trial.
    Vaccine. 2024 Apr 3:S0264-410X(24)00399-2. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
65. GONG JD, Barnboym E, O'Mara M, Gurevich N, et al
    Self-reported determinants of COVID-19 vaccine acceptance among persons with and without autoimmune disease.
    Vaccine. 2024 Mar 30:S0264-410X(24)00373-6. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    
66. MALTEZOU HC, Kontogianni S, Michailidou E, Vergadi E, et al
    Effectiveness of COVID-19 vaccination against school absenteeism in children and adolescents hospitalized with COVID-19.
    Vaccine. 2024 Mar 30:S0264-410X(24)00397-9. doi: 10.1016/j.vaccine.2024.
    PubMed         Abstract available
    
    

    
    Virus Res

67. WANG Z, Sun W, Li D, Sun Y, et al
    A live attenuated influenza B virus vaccine expressing RBD elicits protective immunity against SARS-CoV-2 in mice.
    Virus Res. 2024;345:199378.
    PubMed         Abstract available
    
    
68. KHAIRNAR K, Tomar SS
    COVID-19 genome surveillance: A geographical landscape and mutational mapping of SARS-CoV-2 variants in central India over two years.
    Virus Res. 2024;344:199365.
    PubMed         Abstract available
    
    
69. LUO L, Lv J
    An evolutionary theory on virus mutation in COVID-19.
    Virus Res. 2024;344:199358.
    PubMed         Abstract available
    
    
70. SCHAFER A, Gralinski LE, Leist SR, Hampton BK, et al
    Genetic loci regulate Sarbecovirus pathogenesis: A comparison across mice and humans.
    Virus Res. 2024;344:199357.
    PubMed         Abstract available
    
    
71. SCHMITZ T, Freuer D, Gosslau Y, Warm TD, et al
    Can inflammatory plasma proteins predict Long COVID or Fatigue severity after SARS-CoV-2 infection?
    Virus Res. 2024;344:199363.
    PubMed         Abstract available
    
    
72. KHEMIRI H, Mangone I, Gdoura M, Mefteh K, et al
    Dynamic of SARS-CoV-2 variants circulation in Tunisian pediatric population, during successive waves, from March 2020 to September 2022.
    Virus Res. 2024;344:199353.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Influenza is free of charge.